Anika Therapeutics (ANIK) EPS (Basic) (2010 - 2026)
Anika Therapeutics (ANIK) reported EPS (Basic) of -$0.37 for Q1 2026, down 32.14% year-over-year from -$0.55 in Q1 2025, and down 408.33% quarter-over-quarter from $0.12 in Q4 2025.
Anika Therapeutics (ANIK) EPS (Basic) (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of EPS (Basic) data on file, last reported at -$0.37 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.37, down 32.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.8 (down 8.11% YoY), and the FY2025 annual result was -$0.7, down 16.67% from the prior year.
- EPS (Basic) eased to -$0.37 in Q1 2026 per ANIK's latest filing, from $0.12 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.74 in Q4 2024 and troughed at -$4.3 in Q4 2023.
- A 5-year average of -$0.5 and a median of -$0.29 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) tumbled 1164.71% in 2023, then jumped 140.47% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.34 in 2022, then plunged by 1164.71% to -$4.3 in 2023, then jumped by 140.47% to $1.74 in 2024, then plunged by 93.1% to $0.12 in 2025, then plunged by 408.33% to -$0.37 in 2026.
- Business Quant data shows ANIK's EPS (Basic) at -$0.37 in Q1 2026, $0.12 in Q4 2025, and -$0.22 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.83 |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | -0.22 |
| Jun 30, 2025 | -0.33 |
| Mar 31, 2025 | -0.28 |
| Dec 31, 2024 | 1.74 |
| Sep 30, 2024 | -2.03 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.31 |
| Dec 31, 2023 | -4.30 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.19 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.34 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | -0.20 |
| Mar 31, 2022 | -0.20 |
| Dec 31, 2021 | -0.40 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.45 |